Pharma Pathway

JANUARY 5, 2023

Sun Pharma- Walk-In Drive for EHS & Safety Department On 10th Jan’ 2023. Department: EHS & Safety. Note: Sun Pharma does not seek payment of any kind from a prospective candidates for employment with Sun Pharma or authorize any agency or any individual to collect or charge any fees or charges for recruitment.

Safety 52

Safety Pharma Recruitment Prospecting 52

European Pharmaceutical Review

SEPTEMBER 26, 2023

Depending on the size and complexity of the dataset, pharma companies have the option of several migration methods from which to select the one most suitable for their needs and that maintains regulatory compliance. The list of non-transferable safety case data is fairly normalised for both E2B(R2) and E2B(R3) formats.

Safety 93

Safety Pharma Electronics Pharmaceutical 93

Fierce Pharma

JULY 7, 2023

AstraZeneca and Daiichi Sankyo's TROP2 antibody-drug conjugate returned a concerning safety message. AstraZeneca and Daiichi Sankyo delivered a concerning safety message for their TROP2 antibody-drug conjugate. Moderna reportedly plans to invest up to $1 billion in China.

Safety 252

Safety Pharma 252

Fierce Pharma

JANUARY 22, 2024

As many have feared, the FDA’s investigation into secondary T-cell cancers following treatment with existing CAR-T therapies is poised to lead to a classwide black box warning. |

FDA 341

FDA Safety Leads 341

Fierce Pharma

JANUARY 6, 2024

A group of cell therapy experts, including CAR-T pioneers Drs. Bruce Levine and Carl June, wrote in support of continued use of CAR-T therapy.

Safety 326

Safety Medicine FDA 326

MedCity News

JANUARY 23, 2024

Two months after announcing an inquiry into reports of new cancers in patients treated with CAR T-cell therapies, the FDA is directing makers of these therapies to add new safety warnings to product labels describing this risk. Companies have 30 calendar days to comply.

Safety 102

Safety FDA Patients Biopharma 102

World of DTC Marketing

AUGUST 12, 2022

Such warnings “constitute the pharma response in literally every instance since 1906,” the first drug regulation agency was created, said Dr. Aaron Kesselheim. About 40 percent of drugs fail in preliminary Phase I studies, which assess a drug’s safety in humans and typically cost just $25 million.

Pharma 255

Pharma Retail Pharmaceutical manufacturing Pharmaceutical 255

Fierce Pharma

FEBRUARY 27, 2024

Organon’s inherited asthma med Singulair is back in the spotlight for the wrong reasons after New York Attorney General Letitia James raised fresh concerns about the drug’s neuropsychiatric side ef | Organon’s inherited asthma med Singulair is back in the spotlight for the wrong reasons after New York Attorney General Letitia James raised fresh concerns (..)

Side effects 220

Side effects Safety 220

Fierce Pharma

OCTOBER 26, 2023

With concerns growing over the burden Leqembi could impose on healthcare infrastructure, Eisai and Biogen have trotted out data for an under-the-skin version of the Alzheimer’s disease drug that ma | Eisai and Biogen have trotted out data for a subcutaneous version of the Alzheimer’s disease drug Leqembi.

Safety 294

Safety Healthcare Healthcare 294

World of DTC Marketing

OCTOBER 20, 2020

J&J’s refusal to release any information regarding a COVID-19 vaccination trial that J&J paused earlier this month comes on the heels of a recent and widely-touted joint pledge of prudence and caution on vaccine trial safety by nine drug companies, including J&J, working on COVID 19 vaccines. Pharma still has not learned.

Pharma 214

Pharma Government Physicians Safety 214

Pharma Pathway

SEPTEMBER 21, 2022

Hetero Labs Limited-Walk-In Interviews for EHS- Process Safety Management/ Process Safety Lab On 24th Sept’ 2022. Departments: EHS- Process Safety Management/ Process Safety Lab. Hetero Labs Limited-Walk-In Interviews for EHS- Process Safety Management/ Process Safety Lab On 24th Sept’ 2022.

Safety 83

Safety Management Pharmaceutical Manufacturing 83

Fierce Pharma

JANUARY 25, 2024

Three months after launching an investigation into the risk of patients developing secondary T-cell cancers after receiving a CAR-T drug, the FDA has shared more information on the cases it has see | Three months after launching an investigation into the risk of secondary T-cell cancers after treatment with a CAR-T medicine, the FDA has shared more (..)

Safety 286

Safety FDA Medicine Patients 286

World of DTC Marketing

FEBRUARY 4, 2021

The company decided there were too few reports of serious depression and suicidal behavior and not enough specifics about those cases to warrant more than “routine” monitoring of safety data. The national vaccine safety surveillance program run by the Centers for Disease Control and Prevention (CDC) and the U.S. COVID Dashboards.

Pharma 180

Pharma Food and Drug Administration Side effects Safety 180

LEVO Health

FEBRUARY 8, 2024

By prioritizing specific HCP marketing strategies, pharma marketers can achieve more effective outreach and forge stronger, more enduring relationships with their target audience. Therefore, pharma companies are investing heavily in digital marketing strategies to reach and engage with HCPs.

Marketing 52

Marketing Pharma Safety Healthcare 52

MedCity News

JUNE 11, 2023

With animal testing requirements finally removed, the pharma industry and its constituents can hope for faster innovation. Human tissues, coupled with AI that can deal with terabytes of data will blow mice models out of the water.

Safety 104

Safety Medical Pharma Biopharma 104

Fierce Pharma

DECEMBER 9, 2023

BCMA-targeted therapies are transforming care for multiple myeloma patients. But these immunotherapies also come with various potentially dangerous side effects. | A new study examined side effect reports of BMCA immunotherapies from the FDA Adverse Event Reporting System, hoping to help inform doctors in their treatment decisions.

Side effects 286

Side effects FDA Safety Doctors 286

MedCity News

JULY 6, 2023

While the agency’s regulatory decision sets precedent for other Alzheimer’s drugs, it also flags serious safety risks. Six months after Esai Alzheimer’s disease drug Leqembi received accelerated FDA approval, the agency has awarded the drug full approval.

Safety 94

Safety FDA Biopharma Pharma 94

World of DTC Marketing

NOVEMBER 27, 2020

SUMMARY: Business by press release has made pharma executives a lot of money but we still haven’t seen any over reviewed data on COVID 19 vaccines. Pharma companies have also been capitalizing on the pandemic and positive press releases more broadly. It seems that we were premature to think that pharma is earning trust back.

Pharma 208

Pharma Food Safety Management 208

Fierce Pharma

NOVEMBER 29, 2023

The revelation of an FDA investigation< | As industry watchers deliberate the implications from the FDA's investigation into secondary cancer risks from CAR-T medicines, an upcoming expert meeting could offer precious clarity from drug regulators.

FDA 260

FDA Safety Medicine 260

pharmaphorum

JULY 6, 2022

And how can regulators balance timely access with robust safety? Timely access and robust safety, however, are not mutually exclusive, and the EFPIA has already made a number of recommendations which it believes would achieve both. The post Are timely access and robust safety mutually exclusive? Accelerating safe access.

Safety 97

Safety FDA Medicine Patients 97

World of DTC Marketing

FEBRUARY 9, 2021

6ix: Safety information needs context. 9ine: “Why aren’t pharma websites updated?” In the top pharma product websites that we showed groups, they really disliked the website’s overall appearance and described it as “cold and unappealing.” First impressions are 94% design-related.

Pharma 180

Pharma Side effects Medical FDA 180

MedCity News

JANUARY 2, 2024

Longboard Pharmaceuticals’ epilepsy drug candidate bexicaserin met the main efficacy goal of its Phase 1b/2a study along with safety data suggesting a potential edge over current treatments. With Longboard now preparing to advance to Phase 3 testing, its stock price soared more than 300%.

Safety 126

Safety Pharma Pharmaceutical Biopharma 126

Pharma Pathway

FEBRUARY 27, 2023

Aurobindo Pharma-Walk-In Interviews for Production/ Quality Control/ Packing On 5th Mar’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). Greetings from Aurobindo Pharma !!! Date: 5th Mar’ 2023 Venue Details: Aurobindo Pharma Ltd, Unit-XV, JN Pharma City, Parawada, Visakhapatnam Dist , A.P.

Pharma 83

Pharma Pharmaceutical manufacturing Safety Manufacturing 83

Fierce Pharma

JULY 12, 2023

Fighting for a place in the competitive atopic dermatitis market, Incyte hopes to reach younger patients with its JAK inhibitor cream Opzelura. Fighting for a place in the competitive atopic dermatitis market, Incyte hopes to reach young patients with its JAK inhibitor cream Opzelura.

Safety 222

Safety Competition Marketing Patients 222

Pharma Pathway

FEBRUARY 4, 2023

Aurobindo Pharma-Walk-In Interviews for B.Sc On 6th Feb’ 2023 @ Aurobindo Pharma Department: Production Qualification: B.Sc As part of Covid-19 safety measures, candidates are requested to sanitize their hands at the entrance, Maintain social distance and ware face mask before entering the venue.

Pharma 87

Pharma Safety 87

Pharma Pathway

JANUARY 27, 2023

Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 28th Jan’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). Greetings from Aurobindo Pharma !!! Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 28th Jan’ 2023

Pharma 84

Pharma Pharmaceutical manufacturing Education Safety 84

pharmaphorum

NOVEMBER 27, 2022

Supply chain challenges take many forms in pharma – from capacity issues, to managing excess safety stock, and ensuring accurate supplier communication. Cutting down on safety stock. Here’s how applying automaton in pharmaceutical labs can help address these. Reducing capacity issues. Better communication with traceable data.

Pharma 105

Pharma Safety Pharmaceutical Manufacturing 105

Pharma Pathway

SEPTEMBER 15, 2022

Aurobindo Pharma-Walk-In Interviews for QC/ QA/ Production Departments On 17th Sept’ 2022. Company Profile: Aurobindo Pharma Ltd’ (APL). Walk-In Interviews for QC/ QA/ Production Departments On 17th Sept’ 2022 @ Aurobindo Pharma Ltd . Job Description. Greetings from Aurobindo !!! Experience: 1 to 5 years.

Pharma 88

Pharma Pharmaceutical manufacturing Safety Manufacturing 88

Fierce Pharma

DECEMBER 22, 2023

As the FDA investigates a safety signal for approved CAR-T therapies, the agency has upgraded a warning about secondary cancers resulting from use of Johnson & Johnson and Legend Biotech’s Carv | As the FDA investigates a safety signal for approved CAR-T therapies, the agency has elevated a warning about secondary cancers resulting from use of (..)

FDA 298

FDA Safety 298

Pharma Pathway

JANUARY 3, 2023

Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 7th Jan’ 2023. Company Profile: Aurobindo Pharma Ltd’ (APL). Greetings from Aurobindo Pharma !!! Walk-In Interviews for QA- IPQA/ Quality Control Department @ Aurobindo Pharma. Job Description. Departments: QA- IPQA/ Quality Control.

Pharma 75

Pharma Pharmaceutical manufacturing Manufacturing Education 75

Pharma Pathway

FEBRUARY 2, 2023

Mankind Pharma Limited- Openings for AGL/ GL -API Technology Transfer -Apply Now Job Description Openings for AGL/ GL -API Technology Transfer Department @ Mankind Pharma Limited Department: AGL/ GL -API Technology Transfer Qualification : B.Tech/ B.E/ Ensuring personal safety in place. Provide training to team members.

Pharma 84

Pharma Engineering Training Safety 84

Pharma Pathway

FEBRUARY 6, 2023

Aurobindo Pharma-Walk-In Interviews for B.Sc On 8th Feb’ 2023 @ Aurobindo Pharma Department: Production Qualification: B.Sc As part of Covid-19 safety measures, candidates are requested to sanitize their hands at the entrance, Maintain social distance and ware face mask before entering the venue. Chemistry in Production Dept.

Pharma 74

Pharma Safety 74

Fierce Pharma

JULY 31, 2023

For Apellis Pharmaceuticals, the emergence of rare but serious side effects has cast a pall over the launch of the company’s geographic atrophy med Syfovre. While touting the “strong commercial execution” of Syfovre’s launch, Apellis’ CEO Cedric Francois, M.D.,

Side effects 194

Side effects Safety Pharmaceutical 194

World of DTC Marketing

MARCH 16, 2021

As a pharma marketer who has worked in many other therapeutic categories and recently on a Covid launch, I have become acutely aware of the interaction between national poles and the on-the-ground sentiment I have observed. The post Do pharma marketers have a responsibility to the public?

Marketing 180

Marketing Pharma Specialization Doctors 180

Pharma Pathway

JANUARY 24, 2023

Hetero Labs Limited-Walk-In Interviews for Quality Control/ Quality Assurance/ Engineering/ Safety -EHS On 29th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Dear, Greetings from Hetero…!!

Engineering 74

Engineering Safety Pharmaceutical Manufacturing 74

Pharma Pathway

SEPTEMBER 20, 2022

Eugia Pharma -Walk-In Interviews for Production/ Warehouse / Quality Assurance/ Quality Control/ Microbiology On 24th Sept’ 2022. Eugia Pharma Specialities Limited is Subsidiary of Aurobindo Pharma Limited, Aurobindo Pharma Ltd’ (APL). Job Description. Experience: 3 years to 10 years.

Pharma 86

Pharma Pharmaceutical manufacturing Specialization Safety 86

Pharma Pathway

JANUARY 26, 2023

As part of Covid-19 safety measures, candidates are requested to sanitize their hands at the entrance, Maintain social distance and ware face mask before entering the venue. Annora Pharma -Walk-In Interview for Freshers & Experienced in Production-Mfg/ Packing On 27th Jan’ 2023 No 261 Plot No. No 261 Plot No.

Pharma 71

Pharma Safety 71